newsfilter
← Latest News
GlobeNewswire·

Harpoon Therapeutics to Participate in the Canaccord Horizons in Oncology Conference

SOUTH SAN FRANCISCO, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ:HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced that Julie Eastland,